Bullous pemphigoid during long-term TNF-alpha blocker therapy.
Matteo
M
Bordignon
Anna
A
Belloni-Fortina
Barbara
B
Pigozzi
Marco
M
Tarantello
Mauro
M
Alaibac
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D010391:Pemphigoid, Bullous / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept